In addition to BCR-ABL1-mediated suppression of HR and NHEJ [132], Piao and colleagues showed that ALL cells carrying the TCF3-HLF chimera were hypersensitive to olaparib, both in vitro and in vivo in combination with temozolomide (Fig. 5C). Here, HLF is linked to acute lymphoblastic leukemia.